title: Low-dose cyclosporin therapy for recombinant erythropoietin-induced pure red-cell aplasia.
authors.affiliation: Department of Renal Medicine, Royal Infirmary, Lauriston Place, Edinburgh, UK. j.duffield@ed.ac.uk
authors.forename: Jeremy S
authors.initials: JS
authors.lastname: Duffield
authors.forename: Susan
authors.initials: S
authors.lastname: Mann
authors.forename: Lichel
authors.initials: L
authors.lastname: Horn
authors.forename: Robin J
authors.initials: RJ
authors.lastname: Winney
mesh_terms: D016572:Cyclosporine / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004921:Erythropoietin / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007676:Kidney Failure, Chronic / Q000175:diagnosis / Q000628:therapy; D008875:Middle Aged; D011994:Recombinant Proteins; D012010:Red-Cell Aplasia, Pure / Q000139:chemically induced* / Q000188:drug therapy*; D018570:Risk Assessment; D016896:Treatment Outcome
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin; D016572:Cyclosporine